Literature DB >> 20940399

Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.

Minji Jo1, Boryana M Eastman, Drue L Webb, Konstantin Stoletov, Richard Klemke, Steven L Gonias.   

Abstract

Signaling by urokinase-type plasminogen activator receptor (uPAR) can cause epithelial-mesenchymal transition (EMT) in cultured breast cancer cells. In this report, we show that uPAR signaling can also induce cancer stem cell (CSC)-like properties. Ectopic overexpression of uPAR in human MDA-MB-468 breast cancer cells promoted the emergence of a CD24(-)/CD44(+) phenotype, characteristic of CSCs, while increasing the cell surface abundance of integrin subunits β1/CD29 and α6/CD49f that represent putative mammary gland stem cell biomarkers. uPAR overexpression increased mammosphere formation in vitro and tumor formation in an immunocompromized severe combined immunodeficient (SCID) mouse model of orthotopic breast cancer. Hypoxic conditions that are known to induce EMT in MDA-MB-468 cells also increased cell surface β1/CD29, mimicking the effects of uPAR overexpression. Antagonizing uPAR effector signaling pathways reversed the increase in cell surface integrin expression. Whereas uPAR overexpression did not induce EMT in MCF-7 breast cancer cells, CSC-like properties were nevertheless still induced along with an increase in tumor initiation and growth in the orthotopic setting in SCID mice. Notably, in MCF-7 cell mammospheres, which display a well-defined acinus-like structure with polarized expression of E-cadherin and β1-integrin, cell collapse into the central cavity was decreased by uPAR overexpression, suggesting that uPAR signaling may stabilize epithelial morphology. In summary, our findings show that uPAR signaling can induce CSC-like properties in breast cancer cells, either concomitantly with or separately from EMT. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940399      PMCID: PMC2970644          DOI: 10.1158/0008-5472.CAN-10-1936

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  Integrin signaling revisited.

Authors:  M A Schwartz
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

Review 2.  uPAR: a versatile signalling orchestrator.

Authors:  Francesco Blasi; Peter Carmeliet
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

Review 3.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

Authors:  M V Carriero; S Del Vecchio; M Capozzoli; P Franco; L Fontana; A Zannetti; G Botti; G D'Aiuto; M Salvatore; M P Stoppelli
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.

Authors:  Y Wei; J A Eble; Z Wang; J A Kreidberg; H A Chapman
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

6.  Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

Authors:  T Tarui; A P Mazar; D B Cines; Y Takada
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

7.  Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.

Authors:  Minji Jo; Keena S Thomas; Denise M O'Donnell; Steven L Gonias
Journal:  J Biol Chem       Date:  2002-11-07       Impact factor: 5.157

8.  EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.

Authors:  David Liu; Julio Aguirre Ghiso; Yeriel Estrada; Liliana Ossowski
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

9.  Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.

Authors:  L Kjøller; A Hall
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

10.  Regulation of Rac1 activation by the low density lipoprotein receptor-related protein.

Authors:  Zhong Ma; Keena S Thomas; Donna J Webb; Radim Moravec; Ana Maria Salicioni; Wendy M Mars; Steven L Gonias
Journal:  J Cell Biol       Date:  2002-12-23       Impact factor: 10.539

View more
  41 in total

1.  A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.

Authors:  Boryana M Eastman; Minji Jo; Drue L Webb; Shinako Takimoto; Steven L Gonias
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

2.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

Review 3.  A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.

Authors:  Eun-Ryeong Hahm; Su-Hyeong Kim; Krishna B Singh; Kamayani Singh; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

4.  Tumor dormancy in bone.

Authors:  Vera Mayhew; Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-29

5.  uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.

Authors:  Jingjing Hu; Minji Jo; Boryana M Eastman; Andrew S Gilder; Jack D Bui; Steven L Gonias
Journal:  Am J Pathol       Date:  2014-10-11       Impact factor: 4.307

6.  Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues.

Authors:  D S Lang; S Marwitz; U Heilenkötter; W Schumm; O Behrens; R Simon; M Reck; E Vollmer; T Goldmann
Journal:  Pathol Oncol Res       Date:  2014-03-09       Impact factor: 3.201

7.  Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.

Authors:  Mingli Han; Manran Liu; Yimeng Wang; Zhiqiang Mo; Xiaokai Bi; Zhirong Liu; Yuanming Fan; Xin Chen; Chengyi Wu
Journal:  Mol Cell Biochem       Date:  2011-12-21       Impact factor: 3.396

8.  Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.

Authors:  Anuradha Sehrawat; Su-Hyeong Kim; Andreas Vogt; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2012-12-30       Impact factor: 4.944

9.  Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Authors:  Begoña Martin-Castillo; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Silvia Cufí; José Manuel Moreno; Bruna Corominas-Faja; Ander Urruticoechea; Ángel G Martín; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.

Authors:  Su-Hyeong Kim; Catherine H Kaschula; Nolan Priedigkeit; Adrian V Lee; Shivendra V Singh
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.